Own the gold standard ✨ in financial data & analytics

Subscribe for $2
Overview
Profile

Alteogen Stock

196170.KQ
KR7196170005

Price

272,500.00 KRW
Today +/-
+0 KRW
Today %
+0 %
P

Alteogen Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Alteogen, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Alteogen from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Alteogen’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Alteogen. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Alteogen’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Alteogen’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Alteogen’s growth potential.

Alteogen Revenue, EBIT and net profit per share

DateAlteogen RevenueAlteogen EBITAlteogen Net Income
2025e75.25 B KRW32.98 B KRW-1.72 B KRW
2024e86.05 B KRW-14.29 B KRW7.24 B KRW
202396.52 B KRW-9.74 B KRW-3.37 B KRW
202228.81 B KRW-29.37 B KRW-8.15 B KRW
202138.75 B KRW-15.19 B KRW-6.27 B KRW
202042.43 B KRW104 M KRW-970 M KRW
201929.23 B KRW-2.25 B KRW-705 M KRW
201813.7 B KRW-7.66 B KRW-6.87 B KRW
201712.1 B KRW-6.17 B KRW-7.45 B KRW
20166.84 B KRW-5.41 B KRW-3.59 B KRW
20154.73 B KRW124 M KRW1.21 B KRW
20147.04 B KRW724 M KRW931 M KRW
20135.53 B KRW1.51 B KRW1.61 B KRW
20123.96 B KRW1.66 B KRW1.43 B KRW

Alteogen Stock Ratios

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B KRW)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B KRW)EBIT (B KRW)EBIT MARGIN (%)NET INCOME (B KRW)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
2012201320142015201620172018201920202021202220232024e2025e
3.965.537.044.736.8412.113.729.2342.4338.7528.8196.5286.0575.25
-39.5727.43-32.8844.7976.8613.21113.3045.15-8.68-25.65235.08-10.85-12.56
86.3168.3255.0373.209.198.5514.2837.9844.2114.9415.7332.32--
3.423.783.883.460.631.041.9611.118.765.794.5331.200
1.661.510.720.12-5.41-6.17-7.66-2.250.1-15.19-29.37-9.74-14.2932.98
41.9227.3410.282.62-79.06-51.01-55.90-7.700.25-39.21-101.97-10.09-16.6143.83
1.431.610.931.21-3.59-7.45-6.87-0.71-0.97-6.27-8.15-3.377.24-1.72
-11.99-42.0329.75-396.94107.67-7.75-89.7437.59546.8029.84-58.62-314.86-123.69
6172837363738404260.7451.2851.6600
--------------
Details

Keystats

ⓘ

Revenue and Growth

The Alteogen Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Alteogen is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M KRW)RECEIVABLES (M KRW)OTHER REC. (M KRW)INVENTORIES (M KRW)OTHER CURRENT LIAB. (M KRW)CURRENT ASSETS (M KRW)TANGIBLE ASSETS (M KRW)LONG-T. INVEST. (M KRW)LONG-T. REC. (M KRW)INTANGIBLE ASSETS (M KRW)GOODWILL (M KRW)OTHER NON-CURRENT ASSETS (M KRW)NON-CURRENT ASSETS (M KRW)TOTAL ASSETS (M KRW)LIABILITIESCOMMON STOCK (M KRW)ADDITIONAL PAID-IN CAPITAL (M KRW)RETAINED EARNINGS (M KRW)OTHER EQUITY (M KRW)UNREAL. GAINS/LOSSES (M KRW)EQUITY (M KRW)LIABILITIES (M KRW)PROVISIONS (M KRW)OTHER SHORT-TERM LIAB. (M KRW)SHORT-TERM DEBTS (M KRW)LONG-TERM DEBT PORTION (M KRW)SHORT-TERM REC. (M KRW)LONG-T. LIAB. (M KRW)DEFERRED TAXES (M KRW)OTHER LIAB. (M KRW)LONG-T. LIABILITIES (M KRW)DEBT (M KRW)TOTAL CAPITAL (M KRW)
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Alteogen provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Alteogen's financial health and stability.

Assets

Alteogen's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Alteogen must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Alteogen after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Alteogen's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (B KRW)DEPRECIATION (B KRW)DEFERRED TAXES (M KRW)CHANGES IN WORKING CAPITAL (B KRW)NON-CASH ITEM (B KRW)PAID INTEREST (M KRW)PAID TAXES (M KRW)NET CASH FLOW FROM OPERATING ACTIVITIES (B KRW)CAPITAL EXPENDITURES (M KRW)CASH FLOW FROM INVESTING ACTIVITIES (B KRW)CASH FLOW FROM OTHER INVESTING ACTIVITIES (B KRW)INTEREST INCOME AND EXPENSES (M KRW)NET DEBT CHANGE (B KRW)NET CHANGE IN EQUITY (B KRW)CASH FLOW FROM FINANCING ACTIVITIES (B KRW)CASH FLOW FROM OTHER FINANCING ACTIVITIES (KRW)TOTAL DIVIDENDS PAID (M KRW)NET CHANGE IN CASH FLOW (B KRW)FREE CASH FLOW (M KRW)SHARE-BASED COMPENSATION (M KRW)
20122013201420152016201720182019202020212022
1.431.610.931.21-3.59-7.45-7.07-1.74-3.42-9.19-10.08
0.030.130.170.210.350.420.550.971.872.152.65
00000000000
-0.62-0.06-0.491.270.891.01-2.889.91-2.48-2.311.57
0.380.320.61-0.43-0.821.670.28-0.015.71-0.07-12.02
21000124010126102
001730351038119125829656
1.2321.212.26-3.16-4.35-9.119.131.68-9.42-17.87
-97-597-85-3,920-2,553-785-7,379-8,328-5,493-24,075-42,491
-1.3-2.58-20.03-4.23-5.05-0.32-22.84-21.99-42.92-125.9650.21
-1.2-1.98-19.95-0.31-2.50.47-15.46-13.66-37.42-101.8992.71
00000000000
0.190.3-0.190-0.0801.82.19-0.5104.110.38
0027.480.139.481.6733.656.4476.422.932.56
0.180.2927.290.139.391.6735.458.6375.921072.92
-2.00-6.00--------36.00-22.00
00000000000
0.1-0.298.34-1.591.31-3.163.69-4.534.51-28.3835.29
1,132.81,397.61,125-1,656.6-5,712.3-5,131.9-16,491.7804.3-3,817.1-33,495.46-60,366.5
00000000000

Alteogen stock margins

The Alteogen margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Alteogen. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Alteogen.

  • 3 years

  • 5 years

  • 10 years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Alteogen's sales revenue. A higher gross margin percentage indicates that the Alteogen retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Alteogen's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Alteogen's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Alteogen's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Alteogen. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Alteogen's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Alteogen Margin History

Alteogen Gross marginAlteogen Profit marginAlteogen EBIT marginAlteogen Profit margin
2025e32.32 %43.83 %-2.28 %
2024e32.32 %-16.61 %8.42 %
202332.32 %-10.09 %-3.49 %
202215.73 %-101.97 %-28.28 %
202114.94 %-39.21 %-16.2 %
202044.21 %0.25 %-2.29 %
201937.98 %-7.7 %-2.41 %
201814.28 %-55.9 %-50.15 %
20178.55 %-51.01 %-61.54 %
20169.19 %-79.06 %-52.41 %
201573.2 %2.62 %25.56 %
201455.03 %10.28 %13.22 %
201368.32 %27.34 %29.06 %
201286.31 %41.92 %36.21 %

Alteogen Stock Sales Revenue, EBIT, Earnings per Share

The Alteogen earnings per share therefore indicates how much revenue Alteogen has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Alteogen earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Alteogen's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Alteogen’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Alteogen's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Alteogen Revenue, EBIT and net profit per share

DateAlteogen Sales per ShareAlteogen EBIT per shareAlteogen Earnings per Share
2025e1,416.38 KRW0 KRW-32.32 KRW
2024e1,619.81 KRW0 KRW136.35 KRW
20231,868.43 KRW-188.48 KRW-65.27 KRW
2022561.72 KRW-572.78 KRW-158.85 KRW
2021637.94 KRW-250.13 KRW-103.31 KRW
20201,010.14 KRW2.48 KRW-23.1 KRW
2019730.73 KRW-56.3 KRW-17.63 KRW
2018360.61 KRW-201.58 KRW-180.84 KRW
2017327.14 KRW-166.86 KRW-201.32 KRW
2016190.11 KRW-150.31 KRW-99.64 KRW
2015127.76 KRW3.35 KRW32.65 KRW
2014251.54 KRW25.86 KRW33.25 KRW
2013325.12 KRW88.88 KRW94.47 KRW
2012660 KRW276.67 KRW239 KRW

Alteogen business model

Alteogen is one of the most popular companies on Eulerpool.com.

Alteogen valuation based on historical P/E ratio, EBIT, and P/S ratio.

Alteogen shares outstanding

The number of shares was Alteogen in 2023 — This indicates how many shares 51.66 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Alteogen earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Alteogen's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Alteogen’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Alteogen's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Alteogen Stock splits

In Alteogen's history, there have been no stock splits.
Unfortunately, there are currently no price targets and forecasts available for Alteogen.

Alteogen Earnings Surprises

DateEPS EstimateEPS ActualQuarterly report
9/30/2021110.26 KRW-398.33 KRW (-461.27 %)2021 Q3
6/30/202194.27 KRW-134.17 KRW (-242.33 %)2021 Q2
1

Eulerpool ESG Scorecard© for the Alteogen stock

Eulerpool World ESG Rating (EESG©)

17/ 100

🌱 Environment

16

👫 Social

16

🏛️ Governance

20

Environment

Scope 1 - Direct Emissions
—
Scope 2 - Indirect emissions from purchased energy
—
Scope 3 - Indirect emissions within the value chain
—
Total CO₂ emissions
—
CO₂ reduction strategy
✅
Coal energy
❌
Nuclear power
❌
Animal experiments
✅
Fur & Leather
—
Pesticides
—
Palm Oil
—
Tobacco
❌
Genetically modified organisms
❌
Climate concept
—
Sustainable forestry
—
Recycling regulations
❌
Environmentally friendly packaging
❌
Hazardous substances
❌
Fuel consumption and efficiency
❌
Water consumption and efficiency
❌

Social

Percentage of female employees—
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content❌
Alcohol❌
Weapons—
Firearms
❌
Gambling❌
Military contracts❌
Human rights concept✅
Privacy concept—
Occupational health and safety✅
Catholic✅

Governance (Corporate Governance)

Environmental reporting❌
Stakeholder Engagement❌
Call Back Policies❌
Antitrust law❌

Kontaktformular an uns. The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Alteogen Stock Shareholders

%
Name
Stocks
Change
Date
5.65 % Hyeong (In U)3,000,000012/31/2023
3.79 % Jeong (Hye Sin)2,016,000012/31/2023
19.21 % Park (Sun Jae)10,206,000012/31/2023
1.80 % Kissei Pharmaceutical Co Ltd957,590012/31/2023
1.76 % The Vanguard Group, Inc.935,0244,2693/31/2024
1.17 % Samsung Asset Management Co., Ltd.622,4753262/29/2024
0.76 % BlackRock Institutional Trust Company, N.A.402,439-9,5773/31/2024
0.52 % Park (Su Min)277,000-2,00012/31/2023
0.40 % Mirae Asset Global Investments Co., Ltd.214,5499,4121/31/2024
0.40 % Lee (Sang Mi)211,583012/31/2023
1
2
3
4
5
...
10

Alteogen Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Merck Stock
Merck
SupplierCustomer0,490,610,120,670,07-0,74
Kissei Pharmaceutical Stock
Kissei Pharmaceutical
SupplierCustomer0,26-0,44-0,64-0,49-0,51-0,20
1

Alteogen stock: Frequently Asked Questions

What is the P/E ratio of Alteogen 2024?

The Alteogen P/E ratio is 1,943.42.

What is the P/S ratio of Alteogen 2024?

The Alteogen P/S ratio is 163.59.

What is the AlleAktien quality score of Alteogen?

The AlleAktien quality score for Alteogen is 3/10.

What is the revenue of Alteogen 2024?

The expected Alteogen revenue is 86.05 B KRW.

How high is the profit of Alteogen 2024?

The expected Alteogen profit is 7.24 B KRW.

What is the business model of Alteogen

No history available for Alteogen.

What is the Alteogen dividend?

Alteogen pays a dividend of 0 KRW distributed over payouts per year.

How often does Alteogen pay dividends?

The dividend cannot currently be calculated for Alteogen or the company does not pay out a dividend.

What is the Alteogen ISIN?

The ISIN of Alteogen is KR7196170005.

What is the Alteogen ticker?

The ticker of Alteogen is 196170.KQ.

How much dividend does Alteogen pay?

Over the past 12 months, Alteogen paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Alteogen is expected to pay a dividend of 0 KRW.

What is the dividend yield of Alteogen?

The current dividend yield of Alteogen is .

When does Alteogen pay dividends?

Alteogen pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Alteogen?

Alteogen paid dividends every year for the past 0 years.

What is the dividend of Alteogen?

For the upcoming 12 months, dividends amounting to 0 KRW are expected. This corresponds to a dividend yield of 0 %.

In which sector is Alteogen located?

Alteogen is assigned to the 'Health' sector.

Wann musste ich die Aktien von Alteogen kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Alteogen from 7/11/2024 amounting to 0 KRW, you needed to have the stock in your portfolio before the ex-date on 7/11/2024.

When did Alteogen pay the last dividend?

The last dividend was paid out on 7/11/2024.

What was the dividend of Alteogen in the year 2023?

In the year 2023, Alteogen distributed 0 KRW as dividends.

In which currency does Alteogen pay out the dividend?

The dividends of Alteogen are distributed in KRW.

Other fundamentals and analyses of Alteogen in the deep dive.

Our stock analysis for Alteogen Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Alteogen Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.